Cargando…
Hyperglycemia-induced downregulation of apolipoprotein M expression is not via the hexosamine pathway
BACKGROUND: We previously demonstrated that hyperglycemia could suppress apolipoprotein M (apoM) synthesis both in vivo and in vitro; however, the mechanism of hyperglycemia-induced downregulation of apoM expression is unknown yet. METHODS: In the present study we further examined if hexosamine path...
Autores principales: | Jiang, Bo, Zhang, Xiaoying, Di, Dongmei, Luo, Guanghua, Shi, Yuanping, Zhang, Jun, Berggren-Söderlund, Maria, Nilsson-Ehle, Peter, Xu, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574082/ https://www.ncbi.nlm.nih.gov/pubmed/26377577 http://dx.doi.org/10.1186/s12944-015-0103-5 |
Ejemplares similares
-
TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells
por: Zhu, Chunhua, et al.
Publicado: (2011) -
Decreased Activities of Apolipoprotein M Promoter Are Associated with the Susceptibility to Coronary Artery Diseases
por: Zheng, Lu, et al.
Publicado: (2014) -
Effects of simvastatin on apolipoprotein M in vivo and in vitro
por: Zhang, Xiaoying, et al.
Publicado: (2011) -
Rosiglitazone Enhances Apolipoprotein M (Apom) Expression in Rat's Liver
por: Luo, Guanghua, et al.
Publicado: (2014) -
Intralipid Decreases Apolipoprotein M Levels and Insulin Sensitivity in Rats
por: Zheng, Lu, et al.
Publicado: (2014)